Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2014
12/02/2014US8901277 Interferon alpha mutant and its polyethylene glycol derivative
12/02/2014US8901084 Self-assembling peptide incorporating modifications and methods of use thereof
12/02/2014US8901083 Administration of angiocidin for the treatment of leukemia
12/02/2014US8901082 Immunity-inducing agent and method for detection of cancer
12/02/2014US8901079 Treatment of parkinson's disease via administration of GLI-1 protein
12/02/2014US8901077 Delivery of a gene therapy vector to the brain by convection-enhanced delivery
12/02/2014US8901076 Binding proteins inhibiting the VEGF-A receptor interaction
12/02/2014US8901074 Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
12/02/2014US8901073 Compounds and their effects on feeding behaviour
12/02/2014US8901070 Pharmaceutical compositions comprising pore-forming proaerolysin protein (PRX302)
12/02/2014US8901069 Protein matrix for light-initiated electron transfer
12/02/2014US8900880 Viral citrullinated peptides and uses thereof
12/02/2014US8900846 Nucleic acid modifying enzymes
12/02/2014US8900825 Immunogenic proteins of Leptospira
12/02/2014US8900600 Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy
12/02/2014US8900599 Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
12/02/2014US8900597 Compositions relating to a mutant Clostridium difficile toxin and methods thereof
12/02/2014US8900596 Physicochemical (PCP) based consensus sequences and uses thereof
12/02/2014US8900595 Filovirus vectors and noninfectious filovirus-based particles
12/02/2014US8900594 Oral recombinant Helicobacter pylori vaccine and preparing method thereof
12/02/2014US8900593 Glucagon/GLP-1 receptor co-agonists
12/02/2014US8900591 Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors
12/02/2014US8900589 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
12/02/2014US8900584 Human CDR-grafted antibody and antibody fragment thereof
12/02/2014US8900583 Methods for treatment of brain injury utilizing biologics
11/2014
11/27/2014US20140352001 Novel bacillus thuringiensis gene with lepidopteran activity
11/27/2014US20140352000 Novel bacillus thuringiensis gene with lepidopteran activity
11/27/2014US20140351998 Engineering plants for efficient uptake and utilization of urea to improve crop production
11/27/2014US20140351967 Brassica Plant Comprising a Mutant Indehiscent Allele
11/27/2014US20140351960 Artery- and vein-specific proteins and uses therefor
11/27/2014US20140350453 Bonding tissues and cross-linking proteins with naphthalimide compounds
11/27/2014US20140350229 Method for producing synthetic amylospheroid
11/27/2014US20140350223 Enhanced production and purification of a natural high intensity sweetener
11/27/2014US20140350220 NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN; pE)
11/27/2014US20140350218 Alpha-conotoxin peptides
11/27/2014US20140349946 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
11/27/2014US20140349944 Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases
11/27/2014US20140349940 Prevention and reduction of blood loss
11/27/2014US20140349929 Multivalent fibronectin based scaffold domain proteins
11/27/2014US20140349925 Novel insulin derivatives
11/27/2014US20140349917 Targeted antimicrobial moieties
11/27/2014US20140349893 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
11/27/2014US20140349855 T cell receptor display
11/27/2014US20140349371 Protein Refolding Method
11/27/2014US20140349344 Compositions and methods for purifying bax
11/27/2014US20140349315 Disulphide bond-stabilized functional soluble mhc class ii heterodimers
11/27/2014US20140348904 Exosomes With Transferrin Peptides
11/27/2014US20140348902 Tcl1 peptides for immunotherapy
11/27/2014US20140348870 Immunogenic plasmodium falciparum antigen compositions and uses thereof
11/27/2014US20140348869 Modified meningococcal fhbp polypeptides
11/27/2014US20140348868 Compositions comprising pneumococcal antigens
11/27/2014US20140348867 Isolated Brachyspira and Methods and Compositions for Expanding and Isolating Brachyspira
11/27/2014US20140348865 Immunogens based on an hiv-1 v1v2 site-of-vulnerability
11/27/2014US20140348864 Porcine circovirus type-2 (pcv2) subunit vaccine
11/27/2014US20140348863 Cmv antigens and uses thereof
11/27/2014US20140348862 Prame derived peptides and immunogenic compositions comprising these
11/27/2014US20140348861 Synthetic peptides and random copolymers for the treatment of autoimmune disorders
11/27/2014US20140348859 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
11/27/2014US20140348854 HE4 Based Therapy For Malignant Disease
11/27/2014US20140348842 Tim-3 ligands and methods thereof
11/27/2014US20140348832 Inhibitors of t-cell activation
11/27/2014US20140348826 Engineering multifunctional and multivalent molecules with collagen xv trimerization domain
11/27/2014US20140348817 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
11/27/2014US20140348805 High affinity t cell receptor and use thereof
11/27/2014US20140348798 Seneca valley virus based compositions and methods for treating disease
11/27/2014US20140348794 Aav4 vector and uses thereof
11/27/2014US20140348790 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same
11/27/2014US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions
11/27/2014US20140348781 Conjugates of gm-csf and il-9, compositions and methods related thereto
11/25/2014US8898047 Methods for identifying inhibitors against viruses that use a class I fusion protein
11/25/2014US8895818 Transgenic plants with enhanced agronomic traits
11/25/2014US8895807 RabG3b gene and protein thereof for regulating late stage xylem development, method for promoting plant biomass and transgenic plant comprising the same
11/25/2014US8895715 S100B mini-promoters
11/25/2014US8895713 Clostridial neurotoxins with altered persistency
11/25/2014US8895711 Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
11/25/2014US8895705 Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof
11/25/2014US8895703 CA125 gene and its use for diagnostic and therapeutic interventions
11/25/2014US8895701 Peptide-conjugated oligonucleotide therapeutic and method of making and using same
11/25/2014US8895700 Monkey homolog of human interferon omega
11/25/2014US8895699 Stabilized compounds having secondary structure motifs
11/25/2014US8895694 Glucagon-Like Peptide-1 derivatives and their pharmaceutical use
11/25/2014US8895598 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
11/25/2014US8895507 Modulation of synaptogenesis
11/25/2014US8895504 Amylin derivatives
11/25/2014US8895503 Pharmaceutical composition for transnasal administration of peptide hormones or cytokines
11/25/2014US8895502 β2-glycoprotein I peptide inhibitors
11/25/2014US8895500 Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same
11/25/2014US8895498 GIP and exendin hybrid polypeptides
11/25/2014US8895309 Myostatin inhibition for enhancing muscle and/or improving muscle function
11/25/2014US8895303 Method of cell culture and method of treatment comprising a vEPO protein variant
11/25/2014US8895286 Attenuated pestiviruses
11/25/2014US8895284 Class II human histone deacetylases, and uses related thereto
11/25/2014US8895283 Nucleic acid modifying enzymes
11/25/2014US8895282 Use of a substance for manufacturing of a medicament for treatment of common cold
11/25/2014US8895281 Method for preparing a site-specific physiologically active polypeptide conjugate
11/25/2014US8895277 Legume isoprene synthase for production of isoprene
11/25/2014US8895276 Microorganism variants having hydrocarbon producing ability and method for producing hydrocarbon using the same
11/25/2014US8895272 Methods for the economical production of biofuel from biomass
11/25/2014US8895263 Methods for suppressing toll-like receptor activity
11/25/2014US8895257 Proteins used for the diagnosis of lyme borreliosis
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 2916